Jupiter Neurosciences, Inc. (JUNS) stock
JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.70−0.06 (-3.41%)
Close on Nov 16, 2026Market cap $1.31MP/E –Yield –
Jupiter Neurosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Jupiter Neurosciences's enterprise value was -$99.48K on Nov 11, 2026, against $41.30M a year earlier. Over the last 2 years it ranged from -$159.30K to $322.43M, with a median of $17.67M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$99.48K | -100.3% |
| 2025 | Dec 31, 2025 | $34.27M | -89.4% |
| 2024 | Dec 31, 2024 | $322.43M | – |
See a number that looks wrong?